AU Patent

AU2016256471A1 — Methods of treating cancer

Assigned to Radius Pharmaceuticals Inc · Expires 2017-12-21 · 8y expired

What this patent protects

Disclosed herein are methods of inhibiting tumor growth or producing tumor regression in a subject by administering to the subject a therapeutically effective amount of a combination of palbociclib and RAD1901.

USPTO Abstract

Disclosed herein are methods of inhibiting tumor growth or producing tumor regression in a subject by administering to the subject a therapeutically effective amount of a combination of palbociclib and RAD1901.

Drugs covered by this patent

Patent Metadata

Patent number
AU2016256471A1
Jurisdiction
AU
Classification
—
Expires
2017-12-21
Drug substance claim
No
Drug product claim
No
Assignee
Radius Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.